Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

5.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.7K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

8.5K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
8.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Abnormal Proliferation02:23

Abnormal Proliferation

5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.5K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

1.3K
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Micronuclei: origins, assays, mechanisms, diseases and treatments.

Signal transduction and targeted therapy·2026
Same author

KIF20A inhibits TRIM21-dependent ubiquitination of DHX9 to boost SOX2 stability, enhancing OSCC stemness and ferroptosis resistance.

Cell death & disease·2026
Same author

NLRPs and tumor: research progress from molecular mechanisms to clinical applications.

Oncogene·2025
Same author

The role of B cell immunity in lung adenocarcinoma.

Genes and immunity·2025
Same author

The deubiquitinating enzyme ATXN3 promotes hepatocellular carcinoma progression by stabilizing TAZ.

Cancer gene therapy·2024
Same author

Programmed cell death: molecular mechanisms, biological functions, diseases, and therapeutic targets.

MedComm·2024
Same journal

Neoadjuvant tislelizumab (anti-PD-1 antibody) plus chemotherapy in patients with advanced epithelial ovarian cancer: the exploratory NAIVE trial.

Signal transduction and targeted therapy·2026
Same journal

Next-generation chemogenetic inhibition using a brain-permeant non-prescription agent.

Signal transduction and targeted therapy·2026
Same journal

Osimertinib-induced cardiotoxicity is driven by HDAC-dependent epigenetic repression and rescued by vorinostat.

Signal transduction and targeted therapy·2026
Same journal

Partial downregulation of platelet glycoprotein VI by low affinity antibodies confers sustained and safe antithrombotic protection.

Signal transduction and targeted therapy·2026
Same journal

Extracellular RNA dimension in alternative medicine: processing-dependent integrity and bioactivity of honeysuckle miRNA MIR2911.

Signal transduction and targeted therapy·2026
Same journal

What's past is prologue: epigenetic memory links transient inflammation to future disease.

Signal transduction and targeted therapy·2026
See all related articles

Related Experiment Video

Updated: Dec 18, 2025

Utilizing a Comprehensive Immunoprecipitation Enrichment System to Identify an Endogenous Post-translational Modification Profile for Target Proteins
08:12

Utilizing a Comprehensive Immunoprecipitation Enrichment System to Identify an Endogenous Post-translational Modification Profile for Target Proteins

Published on: January 8, 2018

11.7K

Regulating tumor suppressor genes: post-translational modifications.

Ling Chen1,2, Shuang Liu3, Yongguang Tao4,5,6

  • 1Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Department of Pathology, Xiangya Hospital, School of Basic Medicine, Central South University, 410078, Changsha, Hunan, China.

Signal Transduction and Targeted Therapy
|June 14, 2020
PubMed
Summary
This summary is machine-generated.

Tumor suppressor genes like Rb, p53, and PTEN are regulated by reversible post-translational modifications (PTMs). These PTMs form complex networks influencing cell state and are crucial targets for cancer therapies.

More Related Videos

Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches
05:56

Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches

Published on: October 13, 2022

1.6K
In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells
09:40

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells

Published on: November 2, 2017

7.6K

Related Experiment Videos

Last Updated: Dec 18, 2025

Utilizing a Comprehensive Immunoprecipitation Enrichment System to Identify an Endogenous Post-translational Modification Profile for Target Proteins
08:12

Utilizing a Comprehensive Immunoprecipitation Enrichment System to Identify an Endogenous Post-translational Modification Profile for Target Proteins

Published on: January 8, 2018

11.7K
Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches
05:56

Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches

Published on: October 13, 2022

1.6K
In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells
09:40

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells

Published on: November 2, 2017

7.6K

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Tumor suppressor genes (TSGs) such as retinoblastoma (Rb), p53, and phosphatase and tensin homolog deleted on chromosome ten (PTEN) are critical in preventing cancer.
  • These proteins are functionally interconnected and their activities are modulated by post-translational modifications (PTMs).
  • PTMs, including phosphorylation, SUMOylation, and acetylation, act as regulatory switches for normal cellular processes like cell cycle control and survival.

Purpose of the Study:

  • To review the necessity, characteristics, and mechanisms of PTMs on Rb, p53, and PTEN.
  • To elucidate how these modifications influence the precise and selective functions of these tumor suppressors.
  • To discuss the potential of Rb, p53, and PTEN as predictive, prognostic, and therapeutic targets in cancer treatment.

Main Methods:

  • Literature review focusing on post-translational modifications of Rb, p53, and PTEN.
  • Analysis of the functional interplay between these TSGs and their regulatory PTMs.
  • Synthesis of current knowledge on the role of PTMs in tumorigenesis and cancer therapy.

Main Results:

  • PTMs play a crucial role in regulating the function of key tumor suppressors, Rb, p53, and PTEN.
  • The interactions and modifications of TSGs form complex networks that can lead to abnormal cell proliferation and cancer.
  • TSGs exhibit frequent alterations in cancer, highlighting their significance.

Conclusions:

  • Understanding the PTMs of Rb, p53, and PTEN is essential for comprehending their roles in cancer development.
  • Targeting these modified tumor suppressors offers promising avenues for novel cancer therapies.
  • Rb, p53, and PTEN are valuable targets for predictive, prognostic, and therapeutic strategies in oncology.